Association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma in the phase III CELESTIAL trial Meeting Abstract


Authors: Strasser, S.; Abou-Alfa, G.; Meyer, T.; Cheng, A.; Cicin, I.; Bolondi, L.; Klumpen, H.; Chan, S.; Zagonel, V.; Milwee, S.; Dubey, S.; Kelley, R.; El-Khoueiry, A.
Abstract Title: Association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma in the phase III CELESTIAL trial
Meeting Title: Australian Gastroenterology Week (AGW)
Journal Title: Journal of Gastroenterology and Hepatology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2019 Sept 8-10
Meeting Location: Adelaide, Australia
ISSN: 0815-9319
Publisher: Wiley Blackwell  
Date Published: 2019-09-01
Start Page: 33
End Page: 34
Language: English
ACCESSION: WOS:000483843100049
PROVIDER: wos
PUBMED: 31484220
DOI: 10.1111/jgh.14797
Notes: Meeting Abstract: 439 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa